Clinical trial
Buprenorphine Pharmacology Related to Addiction Treatment - 18
NCT00000236 · National Institute on Drug Abuse (NIDA), NIH · Completed
Key facts
| NCT number | NCT00000236 |
|---|---|
| Title | Buprenorphine Pharmacology Related to Addiction Treatment - 18 |
| Official title | Buprenorphine Pharmacology Related to Addiction Treatment |
| Lead sponsor | National Institute on Drug Abuse (NIDA), NIH |
| Collaborators | University of Vermont |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Opioid-Related Disorders |
| Intervention type | Drug |
| Interventions | Buprenorphine/naloxone |
| Enrollment | 0 |
| First posted | Sep 21, 1999 |
| Last update posted | Aug 17, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: